Could CT radiomics be the new frontier for myocardial tissue characterisation in cardiomyopathies?
Raman B. and Clarke N., (2025), Eur Heart J Cardiovasc Imaging
Large-scale genome-wide association analyses identify novel genetic loci and mechanisms in hypertrophic cardiomyopathy.
Tadros R. et al, (2025), Nat Genet, 57, 530 - 538
Post-Hospitalisation COVID-19 Rehabilitation (PHOSP-R): A randomised controlled trial of exercise-based rehabilitation.
Daynes E. et al, (2025), Eur Respir J
Multiparametric cardiovascular magnetic resonance evaluation of myocardial perfusion, oxygenation, and energetics in hypertrophic cardiomyopathy following cardiac myosin inhibitor therapy.
Finnigan LEM. et al, (2025), Eur Heart J Cardiovasc Imaging, 26
Myocardial disarray and fibrosis across hypertrophic cardiomyopathy stages associate with ECG markers of arrhythmic risk.
Ashkir Z. et al, (2025), Eur Heart J Cardiovasc Imaging, 26, 218 - 228
Long term health outcomes in people with diabetes 12 months after hospitalisation with COVID-19 in the UK: a prospective cohort study.
Gharibzadeh S. et al, (2025), EClinicalMedicine, 79
Demographic-Based Personalized Left Ventricular Hypertrophy Thresholds for Hypertrophic Cardiomyopathy Diagnosis.
Shiwani H. et al, (2024), J Am Coll Cardiol
Quantitative susceptibility mapping at 7 T in COVID-19: brainstem effects and outcome associations.
Rua C. et al, (2024), Brain, 147, 4121 - 4130
1H and 31P MR Spectroscopy to Assess Muscle Mitochondrial Dysfunction in Long COVID
Finnigan LEM. et al, (2024), Radiology, 313
1H and 31P MR Spectroscopy to Assess Muscle Mitochondrial Dysfunction in Long COVID.
Finnigan LEM. et al, (2024), Radiology, 313
Effects of software on myocardial T1 measurements: a 3 T multicentre single vendor phantom study
Atkinson D. et al, (2024)
Incidence of diabetes mellitus following hospitalisation for COVID-19 in the United Kingdom: A prospective observational study.
Tyrer F. et al, (2024), Diabetes Obes Metab
Diagnostic utility of electrocardiogram for screening of cardiac injury on cardiac magnetic resonance in post-hospitalised COVID-19 patients: a prospective multicenter study.
Samat AHA. et al, (2024), Int J Cardiol, 415
Clinical Significance of Myocardial Injury in Patients Hospitalized for COVID-19: A Prospective, Multicenter, Cohort Study.
Shiwani H. et al, (2024), JACC Cardiovasc Imaging, 17, 1320 - 1331
Feasibility of multiorgan risk prediction with routinely collected diagnostics: a prospective cohort study in the UK Biobank.
McCracken C. et al, (2024), BMJ Evid Based Med, 29, 313 - 323
1-year health outcomes associated with systemic corticosteroids for COVID-19: a longitudinal cohort study.
Leavy OC. et al, (2024), ERJ Open Res, 10
Cognitive and psychiatric symptom trajectories 2-3 years after hospital admission for COVID-19: a longitudinal, prospective cohort study in the UK.
Taquet M. et al, (2024), Lancet Psychiatry, 11, 696 - 708
Differentiating Left Ventricular Remodeling in Aortic Stenosis From Systemic Hypertension.
Mahmod M. et al, (2024), Circ Cardiovasc Imaging, 17
CTEPH is an uncommon complication of COVID-19: UK national surveillance and observational screening cohort studies.
Reddy SA. et al, (2024), Eur Respir J